Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments | Market Insights | US | 2022

In 2020, the procedure deferrals due to the COVID-19 pandemic severely impacted the US open surgery instrument market. However, the overall market for open surgery devices in the US will exhibit moderate growth over the forecast period, driven largely by rising penetration of direct energy and closure devices in open procedures as well as the increasing adoption of premium-priced products although rising laparoscopic procedure penetration—and consequently declining open procedure volumes—will hamper market expansion.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for open surgery instruments in the US across an 11-year period.

Related Medtech Insights Reports

Report
ENT Devices – Market Insights – United States
The US ENT device market will grow modestly over the forecast period because a shift toward officebased procedures is driving market expansion. Procedure volume growth will also be driven by the…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Biosurgical Agents – Market Insights – US
The biosurgical agent market in the US will experience modest growth through 2034. This growth will be fueled by rising surgical procedure volumes that require biosurgical agent and strong…